Zobrazeno 1 - 3
of 3
pro vyhledávání: '"785"'
Publikováno v:
Blood. 120:4076-4076
Abstract 4076 OBJECTIVES: To evaluate the comparative effectiveness of lenalidomide (25 mg) plus dexamethasone (40 mg) (LEN/dex) for the treatment of relapsed/refractory multiple myeloma (RRMM) compared to thalidomide and bendamustine. Primary outcom
Autor:
Xiangao Huang, Hearn Jay Cho, Scott Ely, Morton Coleman, Tricia Nardiello, Lloyd J. Old, Selina Chen-Kiang, Ruben Niesvizky, David Jayabalan, Achim A. Jungbluth, Maurizio DiLiberto, Anna Mei, Roger N. Pearse
Publikováno v:
Blood. 116:785-785
Abstract 785 The type I Melanoma Antigen GEne (MAGE) MAGE-A3 is commonly present in primary multiple myeloma cells and its expression is correlated with advanced disease and proliferation. MAGE-A3 belongs to the Cancer-Testis antigen (CTAg) family of
Publikováno v:
Blood. 108:3558-3558
Lenalidomide is an orally active immunomodulatory drug effective in the treatment of multiple myeloma. We evaluated the toxicity and efficacy of MPR combination in a phase I/II study. Patients with newly diagnosed symptomatic multiple myeloma who wer